US Stock MarketDetailed Quotes

CNSP CNS Pharmaceuticals

Watchlist
  • 1.1300
  • +0.0500+4.63%
Close Jul 25 16:00 ET
  • 1.1100
  • -0.0200-1.77%
Post 20:01 ET
3.24MMarket Cap-8P/E (TTM)

CNS Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CNS Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-20.50

+84.17%
Analyst Rating

No Data

CNS Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2021/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2021/Q40.000 / 0.000--

Unlock Free Earnings Estimates

CNS Pharmaceuticals Earnings Reports

  • CNS Pharmaceuticals | 10-Q: Quarterly report

    May 15 17:06 ET

  • CNS Pharmaceuticals | 10-K: Annual report

    Apr 1 17:04 ET

  • CNS Pharmaceuticals: Q3 2023 Earnings Report

    Nov 14, 2023 17:19 ET

  • CNS Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 14, 2023 07:34 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg